Intellia Therapeutics (NTLA:NAS) Fundamental Valuation Report
Fundamental Valuation Report Intellia Therapeutics(NTLA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$64.73 (USD) 03/26/2021 Weighted Valuation$49.50 (USD) Overall RatingOvervalued by 23.5% Valuation Models Comparables: $42.66 (USD) Valuation Methods …
Intellia Therapeutics (NTLA:NAS) Fundamental Valuation Report Read more »
Read More